<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2017-13-150-156</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-1999</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Репродуктивное здоровье и ВРТ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Reproductive health and ART</subject></subj-group></article-categories><title-group><article-title>ОКИСЛИТЕЛЬНЫЙ СТРЕСС АНТИОКСИДАНТНАЯ ТЕРАПИЯ ПРИ ПРЕГРАВИДАРНОЙ ПОДГОТОВКЕ И/ИЛИ ПРИ Б</article-title><trans-title-group xml:lang="en"><trans-title>OXIDIZING STRESS ANTIOXIDANT THERAPY IN PREGRAVIDAR TRAINING AND/OR INFERTILITY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сыркашева</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Syrkasheva</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.,</p><p>Москва</p></bio><bio xml:lang="en"><p>PhD in medicine,</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коротченко</surname><given-names>О. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Korotchenko</surname><given-names>O. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. акад. В. И. Кулакова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kulakov Scientific Center for Obstetrics, Gynaecology and Perinatology of the Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>09</day><month>10</month><year>2017</year></pub-date><volume>0</volume><issue>13</issue><fpage>150</fpage><lpage>156</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сыркашева А.Г., Коротченко О.Е., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Сыркашева А.Г., Коротченко О.Е.</copyright-holder><copyright-holder xml:lang="en">Syrkasheva A.G., Korotchenko O.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/1999">https://www.med-sovet.pro/jour/article/view/1999</self-uri><abstract><p>В течение последних нескольких десятилетий распространенность бесплодия и субфертильности значительно увеличилась, в первую очередь в развитых странах. Факторы внешней среды, такие как загрязнение воздуха и почвы, контакт с различными химикатами, рассматриваются в качестве причины снижения как женской, так и мужской фертильности. Различные факторы образа жизни, такие как питание, наличие хронических заболеваний, стрессы, аллергия, курение и употребление алкоголя, – также рассматриваются как потенциальные причины снижения фертильности.</p><p>Токсическое воздействие различных вредных веществ на репродуктивную систему человека может приводить к нарушению синтеза стероидных гормонов, а также к прямому повреждению тканей репродуктивных органов. Известно, что основным патофизиологическим механизмом негативного влияния токсических веществ на репродукцию является развитие окислительного стресса – важного компонента различных серьезных заболеваний человека.</p><p>Антиоксиданты — группа лекарственных препаратов, которые нейтрализуют свободные радикалы. К антиоксидантам относятся различные витамины, минералы, а также полиненасыщенные жирные кислоты. Различные антиоксиданты (в виде биологически активных добавок) и поливитамины часто назначаются в качестве прегравидарной подготовки женщинам и мужчинам, планирующим естественную беременность и испытывающим трудности с зачатием, или пациентам на этапе подготовки к программе вспомогательных репродуктивных технологий (ВРТ). Целью назначения препаратов является увеличение фертильности и повышение эффективности программы ВРТ, однако эффективность подобной терапии окончательно не определена. В данном обзоре литературы представлены современные данные литературы относительно влияния витаминов А, С, Е, омега-3 полиненасыщенных жирных кислот, мелатонина и кофермента Q10 на различные аспекты репродуктивной функции человека. </p></abstract><trans-abstract xml:lang="en"><p>Over the past few decades the incidence of infertility and sub-fertility has increased significantly, particularly in developed countries. External environmental factors, such as air and soil pollution, contact with different chemicals, are consdiered as the cause of both female and male fertility decline. Various lifestyle factors, such as nutrition, chronic diseases, stress, allergies, smoking and alcohol consumption, are also seen as potential causes of fertility decline.</p><p>The toxic effects of various harmful substances on a reproductive human system can lead to a disruption of the synthesis of steroid hormones, as well as to the direct damage to the tissue of reproductive organs. It is known that the main pathological mechanism for the negative effects of toxic substances on reproduction is the development of oxidized stress, an important component of various serious human diseases.</p><p>Antioxidants are a group of medications that neutralize the free radicals. Antioxidants include various vitamins, minerals, as well as polyunsaturated fatty acids. Various antioxidants (in the form of biologically active additives) and multivitamins are often indicated as preconception training for women and men who are planning a natural pregnancy and are experiencing a fertility problem or patients in the preparation for the program of auxiliary reproductive technologies (ART). The purpose of the drugs is to increase fertility and increase the effectiveness of the ART program, but the efficacy of such therapy has not been definitively defined.</p><p>This literature review provides the up-to-date literature data on the effects of vitamin A, C, E, omega-3-polyunsaturated fatty acids, melatonin and the Q10 coenzyme on various aspects of the human reproduction function. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>антиоксиданты</kwd><kwd>бесплодие</kwd><kwd>подготовка к беременности</kwd><kwd>омега-3</kwd></kwd-group><kwd-group xml:lang="en"><kwd>antioxidants</kwd><kwd>sterility</kwd><kwd>preparation for pregnancy</kwd><kwd>omega-3</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Jose-miller AB, Boyden JW, Frey KA. Infertility. Am Fam Physician. 2007;75:849–56.</mixed-citation><mixed-citation xml:lang="en">Jose-miller AB, Boyden JW, Frey KA. Infertility. Am Fam Physician. 2007;75:849–56.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gurunath S, Pandian Z, Anderson RA, Bhattacharya S. Defining infertility-a systematic review of prevalence studies. Hum Reprod Update. 2011;17(5):575–88.</mixed-citation><mixed-citation xml:lang="en">Gurunath S, Pandian Z, Anderson RA, Bhattacharya S. Defining infertility-a systematic review of prevalence studies. Hum Reprod Update. 2011;17(5):575–88.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Долгушина Н.В., Ратушняк С.С., Сокур С.А., Глинкина Ж.И., Калинина Е.А. Риск анеуплоидии эмбрионов в программах вспомогательных репродуктивных технологий у мужчин с патозооспермией (мета-анализ). Акушерство и гинекология. 2012; 7: 4–13.</mixed-citation><mixed-citation xml:lang="en">Долгушина Н.В., Ратушняк С.С., Сокур С.А., Глинкина Ж.И., Калинина Е.А. Риск анеуплоидии эмбрионов в программах вспомогательных репродуктивных технологий у мужчин с патозооспермией (мета-анализ). Акушерство и гинекология. 2012; 7: 4–13.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Practice Committee of tAmerican Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. American Society for Reproductive Medicine; 2008, Nov; 90(5 Suppl): S60.</mixed-citation><mixed-citation xml:lang="en">Practice Committee of tAmerican Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. American Society for Reproductive Medicine; 2008, Nov; 90(5 Suppl): S60.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Казанцева Е., Долгушина Н.В., Донников А.Е., Беднягин Л.А., Баранова Е.Е., Терешков П.П. Влияние пренатальной экспозиции бенз(а) пирена, стирола и формальдегида на массу тела при рождении в зависимости от полиморфизмов генов системы детоксикации. Акушерство и гинекология. 2016; 7: 68–78.</mixed-citation><mixed-citation xml:lang="en">Казанцева Е., Долгушина Н.В., Донников А.Е., Беднягин Л.А., Баранова Е.Е., Терешков П.П. Влияние пренатальной экспозиции бенз(а) пирена, стирола и формальдегида на массу тела при рождении в зависимости от полиморфизмов генов системы детоксикации. Акушерство и гинекология. 2016; 7: 68–78.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Казанцева Е., Долгушина Н.В., Ильченко И.Н. Влияние антропогенных химических веществ на течение беременности. Акушерство и гинекология. 2013; 2: 10–7.</mixed-citation><mixed-citation xml:lang="en">Казанцева Е., Долгушина Н.В., Ильченко И.Н. Влияние антропогенных химических веществ на течение беременности. Акушерство и гинекология. 2013; 2: 10–7.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Калинина Е.В., Чернов Н.Н., Новичкова М.Д. Роль глутатиона, глутатионтрансферазы и глутаредоксина в регуляции редокс-зависимых процессов. Успехи биологической химии. 2014; 54: 299–348.</mixed-citation><mixed-citation xml:lang="en">Калинина Е.В., Чернов Н.Н., Новичкова М.Д. Роль глутатиона, глутатионтрансферазы и глутаредоксина в регуляции редокс-зависимых процессов. Успехи биологической химии. 2014; 54: 299–348.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ruder EH, Hartman TJ, Blumberg J, Goldman BM. Oxidative stress and antioxidants: exposure and impact on female fertility. Hum Reprod Update. 2008;14(4): 345–57.</mixed-citation><mixed-citation xml:lang="en">Ruder EH, Hartman TJ, Blumberg J, Goldman BM. Oxidative stress and antioxidants: exposure and impact on female fertility. Hum Reprod Update. 2008;14(4): 345–57.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Meldrum DR, Casper RF, Diez-Juan A, Simon C, Domar AD, Frydman R. Aging and the environment affect gamete and embryo potential: Can we intervene? Fertil Steril [Internet]. Elsevier Inc.; 2016; 105(3): 548–59. Available from: http://dx.doi.org/10.1016/j.fertnstert.2016.01.013.</mixed-citation><mixed-citation xml:lang="en">Meldrum DR, Casper RF, Diez-Juan A, Simon C, Domar AD, Frydman R. Aging and the environment affect gamete and embryo potential: Can we intervene? Fertil Steril [Internet]. Elsevier Inc.; 2016; 105(3): 548–59. Available from: http://dx.doi.org/10.1016/j.fertnstert.2016.01.013.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Иванча К.А., Сыркашева А.Г., Володина М.А., Пятаева С.В., Суханова Ю.А., Высоких М.Ю. и др. Роль маркеров оксидативного стресса в прогнозировании исходов вспомогательных репродуктивных технологий. Акушерство и гинекология. 2017; 5: 98–103.</mixed-citation><mixed-citation xml:lang="en">Иванча К.А., Сыркашева А.Г., Володина М.А., Пятаева С.В., Суханова Ю.А., Высоких М.Ю. и др. Роль маркеров оксидативного стресса в прогнозировании исходов вспомогательных репродуктивных технологий. Акушерство и гинекология. 2017; 5: 98–103.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ehsan M, Moaddab A, Ganji M. Oxidative stress biomarkers in endometrial secretions : A comparison between successful and unsuccessful in vitro fertilization cycles. J Reprod Immunol [Internet]. Elsevier Ireland Ltd; 2016; 116: 70–5. Available from: http://dx.doi. org/10.1016/j.jri.2016.05.003.</mixed-citation><mixed-citation xml:lang="en">Ehsan M, Moaddab A, Ganji M. Oxidative stress biomarkers in endometrial secretions : A comparison between successful and unsuccessful in vitro fertilization cycles. J Reprod Immunol [Internet]. Elsevier Ireland Ltd; 2016; 116: 70–5. Available from: http://dx.doi. org/10.1016/j.jri.2016.05.003.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ruder EH, Hartman T, Reindollar RH, Goldman BM. Female dietary antioxidant intake and time to pregnancy among couples treated for unexplained infertility. Fertil Seril. 2014; 101(3): 759–66.</mixed-citation><mixed-citation xml:lang="en">Ruder EH, Hartman T, Reindollar RH, Goldman BM. Female dietary antioxidant intake and time to pregnancy among couples treated for unexplained infertility. Fertil Seril. 2014; 101(3): 759–66.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa Y, Tanaka H, Akutsu T, Koide K, Sakuma M, Okazaki M et al. Prenatal vitamin A supplementation associated with adverse child behavior at 3 years in a prospective birth cohort in Japan. Pediatr Int. 2016; 58: 855–61.</mixed-citation><mixed-citation xml:lang="en">Ishikawa Y, Tanaka H, Akutsu T, Koide K, Sakuma M, Okazaki M et al. Prenatal vitamin A supplementation associated with adverse child behavior at 3 years in a prospective birth cohort in Japan. Pediatr Int. 2016; 58: 855–61.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Demirel S, Ozkaya MO. Multivitamin and mineral supplementation modulates oxidative stress and antioxidant vitamin levels in serum and follicular fluid of women undergoing in vitro fertilization. Fertil Seril. 2010; 94(6):2465–6.</mixed-citation><mixed-citation xml:lang="en">Demirel S, Ozkaya MO. Multivitamin and mineral supplementation modulates oxidative stress and antioxidant vitamin levels in serum and follicular fluid of women undergoing in vitro fertilization. Fertil Seril. 2010; 94(6):2465–6.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kim K, Bloom MS, Browne RW, Bell EM, Yucel RM, Fujimoto VY. Associations between follicular fluid high density lipoprotein particle components and embryo quality among in vitro fertilization patients. J Assist Reprod Genet [Internet]. Journal of Assisted Reproduction and Genetics; 2016; 34(1): 1–10. Available from: http://dx.doi.org/10.1007/s10815-016-0826-x.</mixed-citation><mixed-citation xml:lang="en">Kim K, Bloom MS, Browne RW, Bell EM, Yucel RM, Fujimoto VY. Associations between follicular fluid high density lipoprotein particle components and embryo quality among in vitro fertilization patients. J Assist Reprod Genet [Internet]. Journal of Assisted Reproduction and Genetics; 2016; 34(1): 1–10. Available from: http://dx.doi.org/10.1007/s10815-016-0826-x.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Best MW, Wu J, Pauli SA, Kane MA, Pierzchalski K, Session DR, et al. A role for retinoids in human oocyte fertilization : regulation of connexin 43 by retinoic acid in cumulus granulosa cells. J Assist Reprod Genet. 2015; 21(6): 527–34.</mixed-citation><mixed-citation xml:lang="en">Best MW, Wu J, Pauli SA, Kane MA, Pierzchalski K, Session DR, et al. A role for retinoids in human oocyte fertilization : regulation of connexin 43 by retinoic acid in cumulus granulosa cells. J Assist Reprod Genet. 2015; 21(6): 527–34.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmadi S, Bashiri R, Ghadiri-anari A. Nadjarzadeh MDA. Antioxidant supplements and semen parameters: An evidence based review. Int J Reprod Biomed. 2016; 14(12): 729– 36.</mixed-citation><mixed-citation xml:lang="en">Ahmadi S, Bashiri R, Ghadiri-anari A. Nadjarzadeh MDA. Antioxidant supplements and semen parameters: An evidence based review. Int J Reprod Biomed. 2016; 14(12): 729– 36.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gual-frau J, Abad C, Amengual MARÍAJ, Hannaoui N, Checa MA, Ribas-maynou J, et al. Oral antioxidant treatment partly improves integrity of human sperm DNA in infertile grade I varicocele patients. Hum Fertil. 2015; 18(January 2014): 1–5.</mixed-citation><mixed-citation xml:lang="en">Gual-frau J, Abad C, Amengual MARÍAJ, Hannaoui N, Checa MA, Ribas-maynou J, et al. Oral antioxidant treatment partly improves integrity of human sperm DNA in infertile grade I varicocele patients. Hum Fertil. 2015; 18(January 2014): 1–5.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bisht S, Dada R. Oxidative stress: Major executioner in disease pathology, role in sperm DNA damage and preventive strategies. Front Biosci. 2017; Jun 1(9): 420–427.</mixed-citation><mixed-citation xml:lang="en">Bisht S, Dada R. Oxidative stress: Major executioner in disease pathology, role in sperm DNA damage and preventive strategies. Front Biosci. 2017; Jun 1(9): 420–427.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Khanaki K, Nouri M, Ardekani AM, Ghassemzadeh A, Sadeghi MR, Darabi M, et al. Evaluation of the Relationship between Endometriosis and Omega-3 and Omega-6 Polyunsaturated Fatty Acids. Iran Biomed J. 2012; 16(January): 38–43.</mixed-citation><mixed-citation xml:lang="en">Khanaki K, Nouri M, Ardekani AM, Ghassemzadeh A, Sadeghi MR, Darabi M, et al. Evaluation of the Relationship between Endometriosis and Omega-3 and Omega-6 Polyunsaturated Fatty Acids. Iran Biomed J. 2012; 16(January): 38–43.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hansen S, Knudsen U. Endometriosis, dysmenorrhoea and diet. Eur J Obs Gynecol Reprod Bio. 2013; 169(2): 162–71.</mixed-citation><mixed-citation xml:lang="en">Hansen S, Knudsen U. Endometriosis, dysmenorrhoea and diet. Eur J Obs Gynecol Reprod Bio. 2013; 169(2): 162–71.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Missmer SA, Chavarro JE, Malspeis S, Bertonejohnson ER, Hornstein MD, Spiegelman D, et al. A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod. 2010; 25(6): 1528–35.</mixed-citation><mixed-citation xml:lang="en">Missmer SA, Chavarro JE, Malspeis S, Bertonejohnson ER, Hornstein MD, Spiegelman D, et al. A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod. 2010; 25(6): 1528–35.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol [Internet]. 2004; 18(5): 671–83. Available from: http://linkinghub.elsevier.com/ retrieve/pii/S1521693404000914.</mixed-citation><mixed-citation xml:lang="en">Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol [Internet]. 2004; 18(5): 671–83. Available from: http://linkinghub.elsevier.com/ retrieve/pii/S1521693404000914.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Azziz R, Tarlatzis R, Dunaif A, Ibanez L, Pugeat M, Taylor A, et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril [Internet]. 2004; 81(1): 19–25. Available from: http://linkinghub.elsevier.com/retrieve/ pii/S001502820302853X.</mixed-citation><mixed-citation xml:lang="en">Azziz R, Tarlatzis R, Dunaif A, Ibanez L, Pugeat M, Taylor A, et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril [Internet]. 2004; 81(1): 19–25. Available from: http://linkinghub.elsevier.com/retrieve/ pii/S001502820302853X.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Phelan N, Connor AO, Tun TK, Correia N, Boran G, Roche HM, et al. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome : results from a cross-sectional analysis and a randomized , placebo-controlled , crossover trial 1–4. Am J Clin Nutr. 2011; 93(3): 652–62.</mixed-citation><mixed-citation xml:lang="en">Phelan N, Connor AO, Tun TK, Correia N, Boran G, Roche HM, et al. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome : results from a cross-sectional analysis and a randomized , placebo-controlled , crossover trial 1–4. Am J Clin Nutr. 2011; 93(3): 652–62.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammadi E, Rafraf M. Benefits of Omega-3 Fatty Acids Supplementation on Serum Paraoxonase 1 Activity and Lipids Ratios in Polycystic Ovary Syndrome. Heal Promot Perspect. 2012;2(2):197–204.</mixed-citation><mixed-citation xml:lang="en">Mohammadi E, Rafraf M. Benefits of Omega-3 Fatty Acids Supplementation on Serum Paraoxonase 1 Activity and Lipids Ratios in Polycystic Ovary Syndrome. Heal Promot Perspect. 2012;2(2):197–204.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammadi E, Rafraf M, Farzadi L. Effects of omega – 3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac J Clin Nutr. 2012;21(July):511–8.</mixed-citation><mixed-citation xml:lang="en">Mohammadi E, Rafraf M, Farzadi L. Effects of omega – 3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac J Clin Nutr. 2012;21(July):511–8.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Zaree M, Sc M, Shahnazi V, Sc M, Fayezi S, Ph D, et al. Expression Levels of PPAR γ and CYP-19 in Polycystic Ovarian Syndrome Primary Granulosa Cells : Influence of ω -3 Fatty Acid. Int J Fertil Steril. 2015;9(2):197–204.</mixed-citation><mixed-citation xml:lang="en">Zaree M, Sc M, Shahnazi V, Sc M, Fayezi S, Ph D, et al. Expression Levels of PPAR γ and CYP-19 in Polycystic Ovarian Syndrome Primary Granulosa Cells : Influence of ω -3 Fatty Acid. Int J Fertil Steril. 2015;9(2):197–204.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Mirabi P, Chaichi MJ, Esmaeilzadeh S, Gholam S, Jorsaraei A, Bijani A. The role of fatty acids on ICSI outcomes : a prospective cohort study. Lipids Health Dis [Internet]. Lipids in Health and Disease; 2017;16(18):1–9. Available from: http://dx.doi.org/10.1186/s12944-016-0396-z</mixed-citation><mixed-citation xml:lang="en">Mirabi P, Chaichi MJ, Esmaeilzadeh S, Gholam S, Jorsaraei A, Bijani A. The role of fatty acids on ICSI outcomes : a prospective cohort study. Lipids Health Dis [Internet]. Lipids in Health and Disease; 2017;16(18):1–9. Available from: http://dx.doi.org/10.1186/s12944-016-0396-z</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Hammiche F, Vujkovic M, Wijburg W, Vries JHM De, Macklon NS, Laven JSE, et al. Increased preconception omega-3 polyunsaturated fatty acid intake improves embryo morphology. Fertil Seril. 2011; 95(5): 1820–3.</mixed-citation><mixed-citation xml:lang="en">Hammiche F, Vujkovic M, Wijburg W, Vries JHM De, Macklon NS, Laven JSE, et al. Increased preconception omega-3 polyunsaturated fatty acid intake improves embryo morphology. Fertil Seril. 2011; 95(5): 1820–3.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Jungheim E, Macones G, Odem R, Patterson B, Moley K. Elevated serum alpha-linolenic acid levels are associated with decreased chance of pregnancy after in vitro fertilization. Fertil Seril. 2012; 96(4): 880–3.</mixed-citation><mixed-citation xml:lang="en">Jungheim E, Macones G, Odem R, Patterson B, Moley K. Elevated serum alpha-linolenic acid levels are associated with decreased chance of pregnancy after in vitro fertilization. Fertil Seril. 2012; 96(4): 880–3.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Safarinejad MR. Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia : a double-blind , placebo-controlled , randomised study. Andrologia. 2011; 43(1): 38–47.</mixed-citation><mixed-citation xml:lang="en">Safarinejad MR. Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia : a double-blind , placebo-controlled , randomised study. Andrologia. 2011; 43(1): 38–47.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Yao DF, Mills JN. Male infertility : lifestyle factors and holistic , complementary , and alternative therapies. Asian J Androl. 2016;18(3):410–8.</mixed-citation><mixed-citation xml:lang="en">Yao DF, Mills JN. Male infertility : lifestyle factors and holistic , complementary , and alternative therapies. Asian J Androl. 2016;18(3):410–8.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Gambone JC, Morris MA, Esposito K, Giugliano D, Ignarro LJ. Lifestyle and metabolic approaches to maximizing erectile and vascular health. Int J Impot Res [Internet]. Nature Publishing Group; 2011;24(2):61–8. Available from: http:// dx.doi.org/10.1038/ijir.2011.51.</mixed-citation><mixed-citation xml:lang="en">Gambone JC, Morris MA, Esposito K, Giugliano D, Ignarro LJ. Lifestyle and metabolic approaches to maximizing erectile and vascular health. Int J Impot Res [Internet]. Nature Publishing Group; 2011;24(2):61–8. Available from: http:// dx.doi.org/10.1038/ijir.2011.51.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res. 2008;44(3):280–7.</mixed-citation><mixed-citation xml:lang="en">Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res. 2008;44(3):280–7.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Eryilmaz OG, Devran A, Sarikaya E. Melatonin improves the oocyte and the embryo in IVF patients with sleep disturbances , but does not improve the sleeping problems. J Assist Reprod Genet. 2011;28(9):815–20.</mixed-citation><mixed-citation xml:lang="en">Eryilmaz OG, Devran A, Sarikaya E. Melatonin improves the oocyte and the embryo in IVF patients with sleep disturbances , but does not improve the sleeping problems. J Assist Reprod Genet. 2011;28(9):815–20.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Unfer V, Raffone E, Rizzo P, Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality : a prospective , longitudinal , cohort study. Gynecol Endocrinol. 2011;27(11):857–61.</mixed-citation><mixed-citation xml:lang="en">Unfer V, Raffone E, Rizzo P, Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality : a prospective , longitudinal , cohort study. Gynecol Endocrinol. 2011;27(11):857–61.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Ortiz A, Espino J, Bejarano I, Lozano G, Monllor F, García J, et al. High endogenous melatonin concentrations enhance sperm quality and short-term in vitro exposure to melatonin improves aspects of sperm motility. J Pineal Res. 2011;50(2):132–9.</mixed-citation><mixed-citation xml:lang="en">Ortiz A, Espino J, Bejarano I, Lozano G, Monllor F, García J, et al. High endogenous melatonin concentrations enhance sperm quality and short-term in vitro exposure to melatonin improves aspects of sperm motility. J Pineal Res. 2011;50(2):132–9.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Kratz A, Piwowar A, Michal Zeman C. Decreased melatonin levels and increased levels of advanced oxidation protein products in the seminal plasma are related to male infertility. Reprod Fertil Dev. 2016;28(4):507–15.</mixed-citation><mixed-citation xml:lang="en">Kratz A, Piwowar A, Michal Zeman C. Decreased melatonin levels and increased levels of advanced oxidation protein products in the seminal plasma are related to male infertility. Reprod Fertil Dev. 2016;28(4):507–15.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Date R, Date R, Date A, Manuscript O. Exogenous melatonin supplementation prevents oxidative stress-evoked DNA damage in human spermatozoa. J Pineal Res. 2014;57(3):333–9.</mixed-citation><mixed-citation xml:lang="en">Date R, Date R, Date A, Manuscript O. Exogenous melatonin supplementation prevents oxidative stress-evoked DNA damage in human spermatozoa. J Pineal Res. 2014;57(3):333–9.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Effects of the Reduced Form of Coenzyme Q 10 ( Ubiquinol ) on Semen Parameters in Men with Idiopathic Infertility: a Double-Blind , Placebo Controlled , Randomized Study. J Urol [Internet]. Elsevier Inc.; 2012;188(2):526–31. Available from: http://dx.doi.org/10.1016/j.juro.2012.03.131.</mixed-citation><mixed-citation xml:lang="en">Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Effects of the Reduced Form of Coenzyme Q 10 ( Ubiquinol ) on Semen Parameters in Men with Idiopathic Infertility: a Double-Blind , Placebo Controlled , Randomized Study. J Urol [Internet]. Elsevier Inc.; 2012;188(2):526–31. Available from: http://dx.doi.org/10.1016/j.juro.2012.03.131.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Lafuente R, González-comadrán M, Solà I, López G, Brassesco M. Coenzyme Q10 and male infertility: a meta-analysis. J Assist Reprod Genet. 2013;30(9):1147–56.</mixed-citation><mixed-citation xml:lang="en">Lafuente R, González-comadrán M, Solà I, López G, Brassesco M. Coenzyme Q10 and male infertility: a meta-analysis. J Assist Reprod Genet. 2013;30(9):1147–56.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Mg S, Brown J, Clarke J, Rj H. Antioxidants for female subfertility (Review). Cochrane Database Syst Rev. 2013;(8):123.</mixed-citation><mixed-citation xml:lang="en">Mg S, Brown J, Clarke J, Rj H. Antioxidants for female subfertility (Review). Cochrane Database Syst Rev. 2013;(8):123.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
